Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Modifications to vaccine delivery that increase serum antibody longevity are of great interest for maximizing efficacy. We have previously shown that a delayed fractional (DFx) dosing schedule (0-1-6 month) — using AS01B-adjuvanted RH5.1 malaria antigen — substantially improves serum IgG durability as compared with monthly dosing (0-1-2 month; NCT02927145). However, the underlying mechanism and whether there are wider immunological changes with DFx dosing were unclear. Here, PfRH5-specific Ig and B cell responses were analyzed in depth through standardized ELISAs, flow cytometry, systems serology, and single-cell RNA-Seq (scRNA-Seq). Data indicate that DFx dosing increases the magnitude and durability of circulating PfRH5-specific B cells and serum IgG1. At the peak antibody magnitude, DFx dosing was distinguished by a systems serology feature set comprising increased FcRn binding, IgG avidity, and proportion of G2B and G2S2F IgG Fc glycans, alongside decreased IgG3, antibody-dependent complement deposition, and proportion of G1S1F IgG Fc glycan. Concomitantly, scRNA-Seq data show a higher CDR3 percentage of mutation from germline and decreased plasma cell gene expression in circulating PfRH5-specific B cells. Our data, therefore, reveal a profound impact of DFx dosing on the humoral response and suggest plausible mechanisms that could enhance antibody longevity, including improved FcRn binding by serum Ig and a potential shift in the underlying cellular response from circulating short-lived plasma cells to nonperipheral long-lived plasma cells.

[1]  M. Pizza,et al.  Synergistic activity of antibodies in the multicomponent 4CMenB vaccine , 2022, Expert review of vaccines.

[2]  A. Ellebedy,et al.  The germinal centre B cell response to SARS-CoV-2 , 2021, Nature reviews. Immunology.

[3]  Timothy C. Yu,et al.  Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. , 2021, Med.

[4]  Rosalind J Wright,et al.  Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine , 2021, Cell.

[5]  Nguyen H. Tran,et al.  Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) , 2021, The Lancet.

[6]  J. Mascola,et al.  A Monoclonal Antibody for Malaria Prevention. , 2021, The New England journal of medicine.

[7]  Harinder Singh,et al.  Cell fate dynamics and genomic programming of plasma cell precursors , 2021, Immunological reviews.

[8]  M. Diamond,et al.  SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses , 2021, Nature.

[9]  P. van Damme,et al.  Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants , 2021, NPJ vaccines.

[10]  G. Alter,et al.  Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination , 2021, Med.

[11]  S. Teichmann,et al.  User-friendly, scalable tools and workflows for single-cell RNA-seq analysis , 2021, Nature Methods.

[12]  Wendi Anne Bacon,et al.  Filter, Plot and Explore Single-cell RNA-seq Data , 2021 .

[13]  G. Bauer The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2 , 2021, International Journal of Infectious Diseases.

[14]  Ji-Yang Wang,et al.  Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis , 2021, International journal of molecular sciences.

[15]  B. Haynes,et al.  Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors , 2021, Cell reports. Medicine.

[16]  S. Teichmann,et al.  Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics , 2021, Science Immunology.

[17]  Nguyen H. Tran,et al.  Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials , 2021, The Lancet.

[18]  M. Asokan,et al.  Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention , 2020, JCI insight.

[19]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[20]  H. Thompson,et al.  Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination , 2020, Vaccine.

[21]  Irene Papatheodorou,et al.  A single-cell RNA-sequencing training and analysis suite using the Galaxy framework , 2020, GigaScience.

[22]  Steven H Kleinstein,et al.  Human germinal centres engage memory and naïve B cells after influenza vaccination , 2020, Nature.

[23]  T. Bousema,et al.  Optimizing RTS,S vaccination strategies: give it your best parting shot. , 2020, The Journal of infectious diseases.

[24]  Linda A. Murray,et al.  A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults , 2020, The Journal of infectious diseases.

[25]  Anton Nekrutenko,et al.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update , 2020, Nucleic Acids Res..

[26]  Khushman Taunk,et al.  Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myeloma. , 2020, International journal of oncology.

[27]  S. Chaudhury,et al.  A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses , 2020, eLife.

[28]  Gennady Korotkevich,et al.  Fast gene set enrichment analysis , 2019, bioRxiv.

[29]  Scott A. Jenks,et al.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations , 2019, Front. Immunol..

[30]  Keiichiro Suzuki,et al.  MZB1 folding and unfolding the role of IgA , 2019, Proceedings of the National Academy of Sciences.

[31]  S. Kappe,et al.  Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies , 2019, Cell.

[32]  G. Alter,et al.  A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis , 2019, Journal of immunological methods.

[33]  Kelvin P Lee,et al.  Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle , 2019, Front. Immunol..

[34]  Daniel W. Kulp,et al.  Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance , 2018, Cell.

[35]  Astrid Gall,et al.  Ensembl 2019 , 2018, Nucleic Acids Res..

[36]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[37]  C. Locht,et al.  Diversion of complement-mediated killing by Bordetella. , 2018, Microbes and infection.

[38]  S. Nutt,et al.  Cochaperone Mzb1 is a key effector of Blimp1 in plasma cell differentiation and β1-integrin function , 2018, Proceedings of the National Academy of Sciences.

[39]  A. Lawrie,et al.  Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells , 2018, npj Vaccines.

[40]  K. Anderson,et al.  Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy , 2018, Front. Immunol..

[41]  J. Rayner,et al.  Malaria Vaccines: Recent Advances and New Horizons , 2018, Cell host & microbe.

[42]  J. Weiner,et al.  Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV , 2018, Journal of immunological methods.

[43]  S. Ito,et al.  Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes , 2018, Arthritis Research & Therapy.

[44]  G. Alter,et al.  Systems serology: profiling vaccine induced humoral immunity against HIV , 2017, Retrovirology.

[45]  Daniel E. Zak,et al.  Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. , 2017, Blood advances.

[46]  M. Mann,et al.  Deep Proteome Profiling Reveals Common Prevalence of MZB1‐Positive Plasma B Cells in Human Lung and Skin Fibrosis , 2017, American journal of respiratory and critical care medicine.

[47]  Juliana K. Wambua,et al.  Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. , 2017, JCI insight.

[48]  G. Alter,et al.  Transfer of maternal immunity and programming of the newborn immune system , 2017, Seminars in Immunopathology.

[49]  A. Wallqvist,et al.  Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis , 2017, Scientific Reports.

[50]  Daniel W. Kulp,et al.  Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches , 2017, Immunity.

[51]  Karen G. Dowell,et al.  Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles , 2017, Journal of immunological methods.

[52]  W. Blackwelder,et al.  Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study , 2016, Clinical and Vaccine Immunology.

[53]  Paige E. Waterman,et al.  Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study. , 2016, The Journal of infectious diseases.

[54]  D. Lauffenburger,et al.  A Functional Role for Antibodies in Tuberculosis , 2016, Cell.

[55]  K. Roskin,et al.  Defining antigen-specific plasmablast and memory B cell subsets in blood following viral infection and vaccination of humans , 2016, Nature Immunology.

[56]  A. Tarakhovsky,et al.  Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation , 2016, Nature Immunology.

[57]  Jerome H. Kim,et al.  Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology , 2015, Cell.

[58]  G. Alter,et al.  Microscale purification of antigen-specific antibodies. , 2015, Journal of immunological methods.

[59]  R. Ahmed,et al.  Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy , 2015, Cell.

[60]  Mikhail Shugay,et al.  MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.

[61]  S. Salzberg,et al.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.

[62]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[63]  M. Flajnik,et al.  Putting J Chain Back on the Map: How Might Its Expression Define Plasma Cell Development? , 2014, The Journal of Immunology.

[64]  R. Grosschedl,et al.  MZB1 is a GRP94 cochaperone that enables proper immunoglobulin heavy chain biosynthesis upon ER stress , 2014, Genes & development.

[65]  W. Shi,et al.  The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity , 2014, The Journal of experimental medicine.

[66]  M. Shlomchik,et al.  A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells. , 2014, Immunity.

[67]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[68]  Julian C. Rayner,et al.  A Library of Functional Recombinant Cell-surface and Secreted P. falciparum Merozoite Proteins* , 2013, Molecular & Cellular Proteomics.

[69]  A. Collins,et al.  A Temporal Model of Human IgE and IgG Antibody Function , 2013, Front. Immunol..

[70]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[71]  C. Bailey-Kellogg,et al.  High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples. , 2012, Journal of immunological methods.

[72]  Jerome H. Kim,et al.  Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial , 2012, Journal of Virology.

[73]  M. Shlomchik,et al.  Germinal center selection and the development of memory B and plasma cells , 2012, Immunological reviews.

[74]  Kwaku Poku Asante,et al.  Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. , 2011, The Lancet. Infectious diseases.

[75]  Shenyuan L. Zhang,et al.  Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells. , 2010, Immunity.

[76]  W. Mitzner,et al.  Lack of antibody affinity maturation due to poor Toll stimulation led to enhanced RSV disease , 2008, Nature medicine.

[77]  Kenneth G. C. Smith,et al.  FcγRIIb controls bone marrow plasma cell persistence and apoptosis , 2007, Nature Immunology.

[78]  Hong Zhou,et al.  Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria , 2005, Infection and Immunity.

[79]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[80]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[81]  K. Tarte,et al.  Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. , 2003, Blood.

[82]  R. Noelle,et al.  Short-lived and Long-lived Bone Marrow Plasma Cells Are Derived from a Novel Precursor Population , 2002, The Journal of experimental medicine.

[83]  J. Cyster,et al.  A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements , 2001, The Journal of experimental medicine.

[84]  A. Lucas,et al.  Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides , 1999, Infection and Immunity.

[85]  Joe D. Cohen,et al.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.

[86]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[87]  Kenneth G. C. Smith,et al.  FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. , 2007, Nature immunology.